Cullinan Therapeutics Q3 EPS $(0.74) Beats $(0.84) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.84) by 11.9 percent. This is a 3.9 percent increase over losses of $(0.77) per share
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.84) by 11.9 percent. This is a 3.9 percent increase over losses of $(0.77) per share from the same period last year.